# Sensitivity of ECG on Detection of Three Different Intravascular Applied Test Doses of Bupivacaine and Epinephrine

Study · id `cardio:ct-nct01091766` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01091766](<https://clinicaltrials.gov/study/NCT01091766>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01091766

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.

## Technical summary

Registry record NCT01091766. Randomized; double masking; primary purpose prevention. Start 2010-03 (registry gives no type); primary completion 2011-07 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 150 participants (enrolled count; ClinicalTrials.gov record NCT01091766, source copy `cardio:ctgov-nct01091766-2012-07-24`, retrieved 2026-10-26)
- Start date: 2010-03 (registry gives no type) (ClinicalTrials.gov record NCT01091766, source copy `cardio:ctgov-nct01091766-2012-07-24`, retrieved 2026-10-26)
- Primary completion: 2011-07 (actual) (ClinicalTrials.gov record NCT01091766, source copy `cardio:ctgov-nct01091766-2012-07-24`, retrieved 2026-10-26)
- Completion: 2011-07 (actual) (ClinicalTrials.gov record NCT01091766, source copy `cardio:ctgov-nct01091766-2012-07-24`, retrieved 2026-10-26)
- Countries: Switzerland (ClinicalTrials.gov record NCT01091766, source copy `cardio:ctgov-nct01091766-2012-07-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01091766-2012-07-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Sensitivity of ECG on Detection of Three Different Intravascular Applied Test Doses of Bupivacaine and Epinephrine
- Condition: Anaesthesia
- Condition: Toxicity
- Intervention (Drug): intravenous injection of test solution
- Intervention (Drug): intravenous injection of test solution
- Intervention (Drug): intravenous injection of test solution
- Lead sponsor: University Children's Hospital, Zurich
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)

## Provenance

Content hash: 2c993c76cef1aa9c9c6438e78667fc5e8a364d7455a1780c1e9df048e778a452
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
